九州大学 · 医学
Yoshimasa Shiraishi教授の研究室では、耐 multidrug および広範な耐性結核（XDR-TB）の診断・治療に関する臨床的研究が中心です。特に、外科的治療としての肺葉切除術の有効性と適応を検証しており、国際基準に則った症例管理と長期フォローアップを実施しています。結核の難治例における多職種連携治療のあり方を模索する、臨床的・実践的な研究が特徴です。
Figures are computed from collected data and may differ slightly.
Japan Registry of Clinical Trials Identifier: jRCT2080224500.
Extensively drug-resistant tuberculosis is becoming a global threat. It is a relatively new phenomenon, and its optimal management remains undetermined. We report our experience in using pulmonary resection for treating patients with this disease. Records were reviewed of 54 consecutive patients undergoing a pulmonary resection for multidrug-resistant tuberculosis at Fukujuji Hospital between 2000 and 2006. These patients were identified using the definition approved by the World Health Organiza
Open papers in the app to read, cite, and organize with AI.
